DATA COORDINATING CENTER FOR THE STUDY OF PREGNANCY AND NEONATAL HEALTH (SPAN)
DATA COORDINATING CENTER FOR THE STUDY OF PREGNANCY AND NEONATAL HEALTH (SPAN)
批准号:
10021081
负责人:
DANIEL MOLINA
金额:
$143.85万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-17 至 2024-07-31
关键词:
AgingAnthropometryCharacteristicsClinical TrialsClinical Trials Data Monitoring CommitteesClinical Trials DatabaseDataData AnalysesData CollectionData Coordinating CenterData SetDatabase Management SystemsDevelopmentDocumentationEnrollmentEpigenetic ProcessFacebookFetal GrowthGeneticGestational DiabetesHealthLongterm Follow-upMonitorNational Institute of Child Health and Human DevelopmentNeonatalNeonatal MortalityNewsletterOnline SystemsPregnancyPreparationRandomizedResearchSchemeSeminal fluidServicesSiteStatistical Data InterpretationSystemTraining ActivityVisitWomancardiovascular risk factorclinical research sitecohortcomputerized data processingdata managementdata quality/integrityearly pregnancyneonatal morbiditypopulation healthprospectiverecruitsocial mediatrial designweb site
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Division of lntramural Population Health Research (DIPHR) requires data coordinating services for the Study of Pregnancy And Neonatal health (SPAN). SPAN is a prospective pregnancy cohort recruiting women in early pregnancy and retaining them throughout pregnancy with potential for long-term follow-up. The Study has three specific aims -
1) Paternal Contribution to DOHaD (DAD aim): Determine paternal cardiovascular risk and semen epigenetic factors associated with fetal growth, neonatal anthropometry, and placental characteristics;
2) Genetics of fetal Growth And Placental aging (gGAP aim): Identify genetic mechanisms underlying fetal growth, neonatal anthropometry, and placental epigenetic aging; and
3) Timing of delivery for GDM (Gestational Diabetes Mellitus) (TIME aim): Perform a clinical trial using an adaptive trial design to determine the optimal timing of delivery for gestational diabetes complicated pregnancies between 38-39 weeks relative to neonatal morbidity and mortality.
This initiative is for the data coordinating services that will ultimately provide the final dataset and statistical analyses of the data that will be collected from the SPAN Study. This study involves multiple study sites that are responsible for recruitment and enrollment. The data coordinating center (DCC) (this task order) is responsible for organizing a data safety and monitoring board (DSMB) for the trial component. The web-based data collection system will be established by the NICHD's Clinical Trial Database (CTDB, https://ctdb.nichd.nih.gov/ctdb/).
SCOPE
To provide data coordinating services for "the Study of Pregnancy And Neonatal Health." The purpose of this task order is to procure the services of a DCC for preparation, training activities, enrollment and data collection and data analysis of the SPAN study. The DCC shall aid in implementing a web-based data management system from the NICHD CTDB. Major responsibilities include coordination and management of data collection, assuring data quality and integrity, producing thorough data documentation, cleaning and verifying the data,
processing, tracking (study visits, data entry and biospecimens), supporting administrative and regulatory requirements and statistical analyses. In addition, the DCC is responsible for reviewing the study website and working closely with the clinical sites to monitor and oversee the study. The DCC is also responsible for providing a randomization scheme and organizing a DSMB for the clinical trial component of the study and providing a plan for the interim analysis of trial findings. Moreover, the DCC will have the responsibility of providing graphic expertise for newsletter development, study website, and social media (e.g. Facebook posts), as needed.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PHASE I COCAINE DRUG INTERACTION STUDY. TO6. NIDA PHARMACOKINETIC ANALYSIS RESOURCE CENTER. 08/10/2023 - 02/09/2025. NIDA REF. NO. N01DA-19-8947.
-
批准号:10937276
-
项目类别:
-
资助金额:$20.23万
-
财政年份:2023
-
负责人:DANIEL MOLINA
-
依托单位:
FY23. TO5. NIDA PHARMACOKINETIC ANALYSIS RESOURCE CENTER. 01/18/2022 - 04/16/2024. NIDA REF. NO. N01DA-19-8947.
-
批准号:10948307
-
项目类别:
-
资助金额:$0.9万
-
财政年份:2022
-
负责人:DANIEL MOLINA
-
依托单位:
NIAID CLINICAL DATA AND SAFETY MANAGEMENT CENTER (CDSMC)
-
批准号:10493771
-
项目类别:
-
资助金额:$781.9万
-
财政年份:2021
-
负责人:DANIEL MOLINA
-
依托单位:
DATA COORDINATING CENTER FOR SPROUTS AGES 6- AND 7- YEARS ASSESSMENTS AND STUDY CLOSEOUT
-
批准号:10271537
-
项目类别:
-
资助金额:$75.52万
-
财政年份:2020
-
负责人:DANIEL MOLINA
-
依托单位:
THE PURPOSE OF THIS REQUIREMENT IS TO PROVIDE OTHER SUPPORT SERVICES TO NIDA AS PART OF CONTRACT PERFORMANCE. SPECIFICALLY, THIS TO INVOLVES WORK DESCRIBED IN TASK G. THE SCOPE OF THIS TASK IS FOR SEV
-
批准号:10044188
-
项目类别:
-
资助金额:$2.44万
-
财政年份:2019
-
负责人:DANIEL MOLINA
-
依托单位:
DATA COORDINATING CENTER FOR THE STUDY OF PREGNANCY AND NEONATAL HEALTH (SPAN)
-
批准号:10271386
-
项目类别:
-
资助金额:$25.58万
-
财政年份:2019
-
负责人:DANIEL MOLINA
-
依托单位:
DATA COORDINATING CENTER FOR SPROUTS AGE 4 ASSESSMENTS
-
批准号:10025879
-
项目类别:
-
资助金额:$33.51万
-
财政年份:2019
-
负责人:DANIEL MOLINA
-
依托单位:
THE PURPOSE OF THE TO REQUIREMENT IS TO CONDUCT A PHASE I STUDY OF CBD-MORPHINE DRUG-DRUG INTERACTION. TRI HAS CLEARLY DEFINED THE OBJECTIVES OF THE TO IN THEIR PROPOSAL SUBMISSION.
-
批准号:10044332
-
项目类别:
-
资助金额:$17.99万
-
财政年份:2019
-
负责人:DANIEL MOLINA
-
依托单位:
IGF::OT::IGF Task Order 4 for Clinical Support for a phase 1 clinical interaction study between lorcaserin and cocaine POP: 08/18/2014 -08/17/2015.
-
批准号:8951967
-
项目类别:
-
资助金额:$55.49万
-
财政年份:2014
-
负责人:DANIEL MOLINA
-
依托单位:
CANCER PREVENTION CLINICAL TRIALS AUDITING & INFORMATICS SUPPORT
-
批准号:9915793
-
项目类别:
-
资助金额:$47.93万
-
财政年份:2014
-
负责人:DANIEL MOLINA
-
依托单位:
CANCER PREVENTION CLINICAL TRIALS AUDITING & INFORMATICS SUPPORT
-
批准号:9262815
-
项目类别:
-
资助金额:$185.0万
-
财政年份:2014
-
负责人:DANIEL MOLINA
-
依托单位:
Cancer Prevention Clinical Trials Auditing & Informatics Support.
-
批准号:8949018
-
项目类别:
-
资助金额:$205.82万
-
财政年份:2014
-
负责人:DANIEL MOLINA
-
依托单位:
IGF::OT::IGF Task Order 4 for Clinical Support for a phase 1 clinical interaction study between lorcaserin and cocaine POP: 08/18/2014 -08/17/2015.
-
批准号:9038824
-
项目类别:
-
资助金额:$17.76万
-
财政年份:2014
-
负责人:DANIEL MOLINA
-
依托单位:
IGF::OT::IGF Task Order 4 for Clinical Support for a phase 1 clinical interaction study between lorcaserin and cocaine POP: 08/18/2014 -08/17/2015.
-
批准号:9430254
-
项目类别:
-
资助金额:$33.16万
-
财政年份:2014
-
负责人:DANIEL MOLINA
-
依托单位:
MEDICAL WRITING, REPORT PREPARATION AND PROJECT MANAGEMENT
-
批准号:7962707
-
项目类别:
-
资助金额:$6.76万
-
财政年份:2005
-
负责人:DANIEL MOLINA
-
依托单位:
CLINICAL AND DATA MANGEMENT SERVICES
-
批准号:8014339
-
项目类别:
-
资助金额:$41.47万
-
财政年份:2005
-
负责人:DANIEL MOLINA
-
依托单位:
CLINICAL AND DATA MANGEMENT SERVICES
-
批准号:7963309
-
项目类别:
-
资助金额:$88.45万
-
财政年份:2005
-
负责人:DANIEL MOLINA
-
依托单位:
海外基金